Location History:
- München, DE (2007 - 2014)
- Munich, DE (2008 - 2015)
Company Filing History:
26 out of 132 
2 out of 2 
1 out of 1 Years Active: 2007-2015
Title: The Innovative Contributions of Sonja Leyrer in Biotechnology
Introduction: Sonja Leyrer is a prominent inventor based in Munich, Germany, known for her significant contributions to the field of biotechnology. With an impressive portfolio of 27 patents, she has made remarkable advancements that focus on innovative vaccine technologies and recombinant virus applications.
Latest Patents: Among her most notable patents is the "Recombinant poxvirus expressing homologous genes inserted." This invention involves a recombinant poxvirus vector designed to express multiple homologous foreign sequences derived from different variants of a microorganism, with a homology of 50% or above. This innovative approach enables the development of vaccines and medicaments aimed at inducing immune responses in living organisms, including humans. Another key patent is the "Flavivirus NS1 subunit vaccine," which pertains to NS1 proteins or their parts from Flaviviruses, particularly Dengue viruses. This invention offers solutions for effective vaccination against various Dengue virus serotypes, showcasing Leyrer’s commitment to enhancing global health through her research.
Career Highlights: Sonja Leyrer has made pivotal contributions during her tenure at leading biotechnology firms, including Bavarian Nordic A/S and Venture Technologies Sdn Bhd. Her work in these organizations has helped pioneer cutting-edge solutions in vaccine development and molecular biology.
Collaborations: Throughout her career, Leyrer has collaborated with distinguished professionals in her field, including Paul Michael Howley and Eva Felder. These partnerships not only reflect her ability to work within teams but also contribute to the impactful nature of her research.
Conclusion: Sonja Leyrer continues to be a driving force in the realm of biotechnology with her inventive work and numerous patents. Her advancements in recombinant virus applications and vaccine technologies are crucial in addressing public health challenges and enhancing disease prevention strategies. The impact of her innovative contributions will undoubtedly resonate within the scientific community and beyond as she continues her journey as an influential inventor in this vital field.